ZOOM Lecture - Trissles 7 Alligaton - Jan 26
Weather Report and Snow Accumulation
- Discussion on local snow totals in West Roxbury, Boston.
- West Roxbury total: 21 inches.
- Longwood Fenway area: 15 inches, reported via social media with measurements.
Transition to Lecture Topic
- The main focus of today's discussion is on Parenteral Dose Forms and their administration.
Review of Previous Discussions
- Parenteral Solutions:
- Common solutions discussed include:
- Dextrose 5%
- Sodium chloride 0.9%
- Focus on how to mix and administer doses within these solutions.
- Administration Techniques:
- Types of administration:
- Bolus
- Intermittent infusion
- Continuous infusion
- Dosage Calculations:
- Doses calculated based on patient weight (pounds/kilograms).
- For instance, a 5 mg/kg dosage example.
- Labeling and Overfill Rule:
- Discussed the importance of proper labeling and the rules regarding overfilling bags.
- Drug Compatibility:
- Use of Handbook of Injectable Drugs to determine drug compatibility with solutions.
Current Lecture Focus
- How to Determine Volume for Drug Solutions:
- Understanding how to establish how much solution is needed for a given dose.
- Formulation of Non-Commercial Solutions:
- Importance of creating solutions not readily available, such as:
- 20% Dextrose Solution
- 30% Dextrose Solution
- 3% Sodium Chloride Solution
- Key Reference:
- Use the ASHP (American Society of Health-System Pharmacists) Handbook of Injectable Drugs as a primary resource.
Key Principles and Calculations
- Solubility of Drugs:
- Each chemical has specific solubilities and concentration ranges.
- Discussed how to identify low and high ranges for solubility.
- Dosage Calculation Example:
- Example provided for Acyclovir dosing in a 78 kg patient:
- Dosage: 5 mg/kg every 8 hours for 7 days.
- Total dosage = 390 mg.
- Compatibility Information:
- Method of looking up how acyclovir mixed in solutions; the concentration studies demonstrate compatibility.
- Examples include:
- 5 grams of acyclovir in 1 L dextrose 5% is compatible.
- Other concentrations assessed for compatibility.
- Establishes the compatible concentration range for acyclovir as 1-10 mg/mL.
Practical Application in Dosing
- Volume Calculation for Patient Appeals:
- Dosing range established; e.g., 390 mg could fit into a volume ranging from 39 mL to 390 mL depending on concentration.
Availability of IV Solutions
- Overview of commercially available dextrose solutions of varying sizes:
- Example sizes: 25 mL, 50 mL, 100 mL, 150 mL, 250 mL.
- Calculation for filling doses into each bag size was explained, ensuring concentrations remain acceptable (within the range of 1-10 mg/mL).
Laboratory Practices
- Steps and procedures to collect data from the ASHP Handbook for practical applications in lab settings.
- Importance of selecting familiar and commonly used solutions; e.g., using Dextrose 5% for calculations to establish appropriate ranges.
- Concept of Allegation Method:
- Used to prepare mixtures of different concentrations.
- Example provided to mix dextrose 50% and dextrose 5% to make dextrose 20%:
- Parts calculation: 50 - 20 = 30 parts of higher concentration; 20 - 5 = 15 parts of lower concentration.
- Final Calculations:
- Example calculation showed how much of each solution to use to achieve a desired concentration.
Final Laboratory Instructions
- Students will perform these calculations and prepare solutions in the lab, keeping in mind compatibility and concentration ranges.
- Emphasis placed on teamwork and collaboration, mirroring real-life practices in pharmacy settings.
Ethical Considerations and Professional Responsibility
- Importance of accuracy and evidence in practice.
- Pharmacists must remain updated on drug compatibilities and thoroughly use available references.
- Pharmacists play a critical role in patient safety and effective medication administration.
Conclusion
- Summary of primary learning objectives and essential steps for practical applications in compounding and administration of injectable drugs.
- Questions encouraged to clarify any procedural or informational uncertainties.